Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. (Q53142665)
Jump to navigation
Jump to search
scientific article published on 21 December 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. |
scientific article published on 21 December 2011 |
Statements
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy. (English)
Eurydiki Michalis
Maria Gkotzamanidou
Evangelos Terpos
Dimitrios Christoulas
Eirini Katodritou
Anastasia Pouli
Sosana Delimpasi
John Meletis
Cornelia Bratengeier
Konstantinos Zervas
21 December 2011
131
6
1466-1471
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference